Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?

A. S. DE VOS ; J. J. VAN DER HELM ; A. MATSER ; M. PRINS ; M. E. E. KRETZSCHMAR | 2013
Dans Addiction (Vol.108, n°6, June 2013) Article : Périodique

Aims: In Amsterdam, HIV prevalence has nearly halved among injecting drug users (IDU) since 1990. Hepatitis C virus (HCV) prevalence also declined; HIV and HCV incidence dropped to nearly zero. We examined possible explanations for these time tr[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015

D. K. VAN SANTEN ; J. J. VAN DER HELM ; K. LINDENBURG ; M. SCHIM VAN DER LOEFF ; M. PRINS | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Background: HIV-positive people who use drugs (PWUD) start antiretroviral therapy (ART) later than other risk groups, and among HCV-positive PWUD, HCV treatment uptake is low. Nowadays, HCV direct-acting antivirals (DAAs) are available and reimb[...]

Plus d'info

Ajouter à la sélection